GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.

THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...

First, a drug like Ozempic mimics the natural GLP-1 hormone in your gut, which slows down digestion in the stomach and gastrointestinal tract. Those who take it feel fuller earlier and longer, and ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Dementia New Study: Ozempic May Lower the Risk of Alzheimer’s Diabetes patients taking semaglutide are less likely to develop dementia, research finds. Posted June 30, 2025 | Reviewed by Devon Frye ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...